All
Gleevec Associated With Long-Term Effectiveness in Treating GIST
For patients with advanced GIST Gleevec, complete surgical removal of metastasis and complete Gleevec response are associated with survival time doubling.
The Days of a Breast Cancer Survivor
Having been through two bouts of breast cancer, I am happy to be on this planet with my family, friends and neighbors.
Prostate Cancer Survivor Encourages Men to Speak Up and Get Tested
Bob Lane, a prostate cancer survivor, discusses the stigma men often feel when talking about prostate cancer.
Ligufalimab Gains FDA Orphan Drug Status for Acute Myeloid Leukemia
The FDA granted orphan drug designation to ligufalimab for AML, reflecting its potential as an immune-based therapy that may offer new options for patients.
Expert Highlights Importance of Understanding Myelofibrosis Treatments
Dr. Prithviraj Bose discusses how patients with myelofibrosis can better understand their options and access the most up-to-date advancements in care.
What the Changing Seasons Taught Me About Cancer and Life
The first day of fall comes on September 22, and every year it feels like a reminder to pause.
Understanding the Importance of Biomarker Testing in Lung Cancer
Dr. Joshua K. Sabari sat down with Terri Conneran at the 2025 World Conference on Lung Cancer for a conversation on the importance of biomarker testing.
How to Individually Tailor Myelofibrosis Treatment Options
Dr. Prithviraj Bose explains how doctors tailor myelofibrosis treatments and how patients can work with their care teams to navigate options.
A Day in the Life of a Breast Cancer Survivor
Since being diagnosed with breast cancer, my life has drastically changed. Time has helped each day become more precious and has caused me to become more grateful.
Jakafi for Myelofibrosis Associated With Skin Cancer, Shingles Risk
For patients with myelofibrosis, there is a risk of non-melanoma skin cancer or shingles among patients who received long-term treatment with Jakafi.
FDA Grants Designation to Investigational Drug for Head and Neck Cancer
The FDA has granted fast track designation to the investigational drug CRB-701 for recurrent or metastatic head and neck squamous cell carcinoma.
Can Anemia or Bleeding Be a Sign of Gastrointestinal Stromal Tumors?
Dr. Rosario Ligresti explained that while many GISTs are found incidentally, larger tumors may cause anemia, bleeding or swallowing issues.
Thanking My Support System From My Cancer Journey
Five years after being diagnosed with colon cancer, I would like to share how my support system continues to play a role in my life after active treatment.
Ibtrozi May Address Unmet Needs In ROS1-Positive Non-Small Cell Lung Cancer
Dr. Geoffrey Liu discussed findings from the phase 2 TRUST-II clinical trial evaluating Ibtrozi (taletrectinib) among patients with ROS1-positive non-small cell lung cancer.
Actively Recruiting Trials for Lung, Biliary, AML and Small Cell Cancer
Early trial results report progression-free survival and response rates for ateganosine, spevatamig, Annamycin and pumitamig; studies are currently enrolling.
The Lessons of the Woods
Walking the woods shows me how to release fear, grief, and expectations, trusting that letting go nourishes growth, resilience and life’s next season.
Prostatectomy Not Guaranteed to be Curative in Prostate Cancer
For men with prostate cancer, radical prostatectomy, or surgical removal of the prostate, isn’t guaranteed to be curative, as one expert explained.
FDA Grants Breakthrough Status to Raludotatug Deruxtecan in Ovarian Cancer
The FDA granted breakthrough therapy designation to R-DXd for adults with CDH6-expressing platinum-resistant ovarian, peritoneal or fallopian tube cancers.
Patient Advocate and Caregiver Shares Advocacy Journey in KRAS Cancers
Dr. Joshua Sabari spoke with advocate Chris Conneran on his journey from caregiver to champion for KRAS-mutant cancer patients and families.
The Seasons of Life: A Metaphor for Identity and Legacy
The changing seasons offer a profound metaphor for the circle of life, an idea that resonates deeply with me.
Real-World Study Finds Benefit of Lutathera in Patients With Lung NETs
Lutathera demonstrated antitumor activity in patients with metastatic bronchopulmonary neuroendocrine tumors.
Tepmetko Associated With Frequent Side Effects for Some With NSCLC
For patients with MET exon 14-altered NSCLC, Tepmetko was associated with frequent side effects, although the safety profile is considered manageable.
Understanding Prostate Cancer Surgery and Highlighting Patient Advocacy
As the prostate cancer treatment landscape continues to evolve, understanding the risks and benefits of each approach is critical for patients.
Standing Up to a Friend’s Cancer Is as Hard as Facing My Own
Receiving a “Stand Up to Cancer Day” email gave me the strength to support a friend through her darkest cancer days.
Using AI to Improve Clinical Trial Access for Those With Lung Cancer
Dr. Josh Sabari and Max Doppelt explore challenges in trial enrollment and the potential of emerging therapies to offer hope for patients diagnosed today.
Understanding Head and Neck Cancer: A Guide for Newly Diagnosed Patients
This guide for newly diagnosed patients provides key information to help you understand your options and have informed conversations with your oncologist.
Standing Up to Cancer: What it Means to Me
When I think about standing up to cancer, I cannot separate the words from my own story.
What Does An Early-Stage Gynecologic Cancer Diagnosis Mean?
Early-stage gynecologic cancer is confined to its original site and often treatable; diagnosis, surgery, and new therapies improve outcomes.
THIO Plus Libtayo Elicits Positive Responses in Advanced NSCLC
For patients with advanced non-small cell lung cancer who progressed on two or more prior regimens, THIO with Libtayo elicited positive responses.
Study Explores THIO Plus Immunotherapy in Advanced Lung Cancer
Dr. Thomas Jankowski explained that THIO, a telomerase inhibitor, is being studied with Libtayo to help overcome resistance in advanced lung cancer.
